Biologics Sports Medicine Ortho Regenerative Technologies Enters Into A Material Transfer Agreement With A Global Strategic Medical Company For Its Ortho-R Rotator Cuff Tear Repair Phase I/II U.S. Clinical Trial byChris StewartFebruary 7, 2022
Biologics Regulatory Sports Medicine Ortho Regenerative Technologies Announces Extension of FDA Clinical Hold of ORTHO-R Investigational New Drug Application byJosh SandbergAugust 20, 2021
Biologics Sports Medicine Ortho Regenerative Technologies Releases New Positive Histology Results From Pivotal Preclinical GLP Rotator Cuff Tear Repair Efficacy Study in Large-Animal Model byJosh SandbergJuly 28, 2020
Biologics Sports Medicine Ortho Regenerative Technologies Announces Positive Results from Pivotal Preclinical Study in Rotator Cuff Tear Repair byChris StewartMarch 13, 2020
Sports Medicine Ortho RTi Announces Initiation of Pivotal Study on Ortho-R for Rotator Cuff Repair byJosh SandbergFebruary 11, 2019
Recon Ortho RTi’s Data selected for Podium Presentation at International Conference byJosh SandbergDecember 12, 2018
Sports Medicine Ortho RTi Receives Notice of Allowance for European Patent Protecting Ortho-R Technology byJosh SandbergMarch 12, 2018
